Adults 18 to 25, any sex, with Smoking or Heavy Episodic Drinking. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participants With Reported 7-day Point Prevalence Abstinence at 3 MonthsPrimary· 3 months post baseline
Point prevalent abstinence was defined as biochemically-verified reports of no smoking in the 7 days prior to the 3 month assessment. Participants reporting no smoking in the past 7 days will be coded as abstinent from cigarettes. Participants with a salivary cotinine level \<11 ng/ml, indicating nonsmoking were considered confirmed nonsmokers
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
3
Tobacco Status Project Intervention
4
Number of Participants With Reported 7-day Point Prevalence Abstinence at 6 MonthsPrimary· 6 months post baseline
Point prevalent abstinence was defined as biochemically-verified reports of no smoking in the 7 days prior to the 6 month assessment. Participants reporting no smoking in the past 7 days will be coded as abstinent from cigarettes. Participants with a salivary cotinine level \<11 ng/ml, indicating nonsmoking were considered confirmed nonsmokers
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
0
Tobacco Status Project Intervention
1
Number of Participants With Reported 7-day Point Prevalence Abstinence at 12 MonthsPrimary· 12 months post baseline
Point prevalent abstinence was defined as biochemically-verified reports of no smoking in the 7 days prior to the 12 month assessment. Participants reporting no smoking in the past 7 days will be coded as abstinent from cigarettes. Participants with a salivary cotinine level \<11 ng/ml, indicating nonsmoking were considered confirmed nonsmokers
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
3
Tobacco Status Project Intervention
0
Number of Participants With a Reduction in Cigarettes Smoked Over TimeSecondary· 3, 6, and 12 months post baseline
A reduction was defined as the number of cigarettes smoked in past 7 days prior to the assessment by 50% or more compared to baseline number of cigarettes at 3, 6, and 12 month
Month 3
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
32
Tobacco Status Project Intervention
35
Month 6
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
35
Tobacco Status Project Intervention
30
Month 12
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
46
Tobacco Status Project Intervention
46
Number of Participants Whom Attempted to Quit Tobacco Use During the Course of TreatmentSecondary· 3, 6, and 12 month post-baseline
An attempt was defined by the participants response to the a question as to whether or not they had made an attempt to quit smoking during the course of treatment at the 3, 6, and 12 months post-baseline assessments. Participants who were determined to have made an attempt at least once during the entire course of treatment were scored as yes or no.
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
49
Tobacco Status Project Intervention
45
Number of Participant Reporting a Readiness to Quit Tobacco Use Over TimeSecondary· 3, 6, and 12 months post-baseline
Readiness to change tobacco use will be assessed with a single-item Readiness Ruler, developed and validated for use with young adult heavy smokers participating in brief intervention and the tobacco item from the Staging Health Risk Assessment (S-HRA) to compare stage of change across tobacco and alcohol use. Plans to limit smoking in next 30 days (or is already). Number of participants ready to change smoking in the next month assessed at 3, 6, and 12 months
Month 3
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
37
Tobacco Status Project Intervention
27
Month 6
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
20
Tobacco Status Project Intervention
23
Month 12
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
34
Tobacco Status Project Intervention
41
Average Score on the Thoughts About Abstinence Questionnaire (Smoking)Secondary· At Baseline
The Thoughts About Abstinence Questionnaire (TAAS, (Hall et al., 1991) is a 3 item self-report questionnaire that measures: 1) desire to quit smoking, 2) expected success at quitting, 3) expected difficulty of quitting on 10-point Likert scales (e.g., 1=no desire to quit/lowest expectation/lowest level of difficulty to 10 = extreme desire to quit/highest expectation of success/highest expected difficulty) was assessed at baseline.
Desire to quit
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
6.1
± 2.6
Tobacco Status Project Intervention
5.9
± 2.5
Expected success
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
4.6
± 2.3
Tobacco Status Project Intervention
5.1
± 2.6
Expected difficulty
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
7.2
± 2.4
Tobacco Status Project Intervention
7.1
± 2.3
Average Number of Days of Heavy Episodic Drinking (HED) Over TimeSecondary· 3, 6, and 12 months post-baseline
HED is defined as the number of days in the past month with 4+ drinks consumed in a a single occasion for women and 5+ drinks for men. HED was assessed at 3, 6 and 12 months.
Month 3
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
4.8
± 7
Tobacco Status Project Intervention
7.6
± 8.2
Month 6
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
3.8
± 5.5
Tobacco Status Project Intervention
6
± 7.8
Month 12
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
3.2
± 5.2
Tobacco Status Project Intervention
5.6
± 7.6
Median Number of Drinks Per Week Over TimeSecondary· 3, 6, and 12 months post-baseline
The number of drinks per week was defined as drinks per week in the past 30 days and assessed at the 3,6,and 12 month assessments.
Month 3
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
4
0 – 12
Tobacco Status Project Intervention
6
0 – 17
Month 6
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
5
0 – 11
Tobacco Status Project Intervention
7
0 – 15
Month 12
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
1
0 – 7.8
Tobacco Status Project Intervention
4
0 – 16
Average Score on the Alcohol Use Disorder Identification Test - Concise (AUDIT-C) Over TimeSecondary· 3, 6, and 12 months post-baseline
Misuse of alcohol in the past year was assessed by the AUDIT-C. The AUDIT-C is a brief alcohol screening instrument that reliably identifies persons who are hazardous drinkers or have active alcohol use disorders (including alcohol abuse or dependence) and consists of 3 questions with a total score ranging from 0-12, and generally the higher the score, the more likely it is that a person's drinking is affecting his or her safety. Each AUDIT-C question has 5 answer choices valued from 0 points to 4 points. In men, a score of 4 or more is considered positive, optimal for identifying hazardous dr
Month 3
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
3.9
± 2.7
Tobacco Status Project Intervention
5
± 2.9
Month 6
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
3.7
± 2.7
Tobacco Status Project Intervention
4.8
± 3
Month 12
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
3.4
± 2.4
Tobacco Status Project Intervention
4.1
± 3.1
Readiness to Change Alcohol Use Over TimeSecondary· 3, 6, and 12 months post-baseline
Readiness to change alcohol use will be assessed with a single-item Readiness Ruler, developed and validated for use with young adult heavy drinkers participating in brief intervention and the alcohol item from the Staging Health Risk Assessment (S-HRA) to compare stage of change across tobacco and alcohol use. Plans to limit drinking in next 30 days (or is already) Proportion of participants ready to change drinking in the next month assessed at 3, 6, and 12 months
Month 3
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
40
Tobacco Status Project Intervention
42
Month 6
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
28
Tobacco Status Project Intervention
38
Month 12
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
42
Tobacco Status Project Intervention
54
Number of Participants With Reported Combined Use Using Tobacco or Alcohol Over TimeSecondary· 3, 6, and 12 months post-baseline
Timeline Follow-back data will be used to calculate the sum of days using any tobacco or binge drinking in the past month.
Month 3
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
48
Tobacco Status Project Intervention
63
Month 6
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
36
Tobacco Status Project Intervention
49
Month 12
Group
Value
95% CI
Tobacco Status Project + Alcohol Intervention
43
Tobacco Status Project Intervention
52
Sponsor's own description
This trial will test the efficacy of a 3-month intervention on Facebook targeting tobacco use and heavy episodic drinking against a 3-month Facebook intervention targeting tobacco use. Both groups will be offered a nicotine patch starter kit. The primary outcome is verified 7-day point prevalence abstinence from smoking at 3, 6, and 12 months.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
NCT07488741 — Comparison of the Effects of Different Chest Techniques on University Students With Smoking Addiction
· NA
· recruiting
NCT07443631 — Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants
· NA
· recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products
· NA
· recruiting
NCT06966258 — Inspire HER: Inspiring the Heart and Emotions for Radical Health
· NA
· recruiting
NCT06713603 — Technology Assisted Motivational Interviewing
· NA
· recruiting
Other University of California, San Francisco trials
Trials by the same sponsor.
NCT05284773 — Screening for Acute Malnutrition
· NA
· withdrawn
NCT04634851 — Video Home Visits for Dietary Counselling
· NA
· not yet recruiting
NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M
· Phase 1, PHASE2
· not yet recruiting
NCT07534098 — Intervention for Hearing Health Among Native Americans
· NA
· not yet recruiting
NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT)
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
Last refreshed: 12 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03163303.